Correlation Between ATyr Pharma and Antibe Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Antibe Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Antibe Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Antibe Therapeutics, you can compare the effects of market volatilities on ATyr Pharma and Antibe Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Antibe Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Antibe Therapeutics.
Diversification Opportunities for ATyr Pharma and Antibe Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ATyr and Antibe is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Antibe Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antibe Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Antibe Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antibe Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Antibe Therapeutics go up and down completely randomly.
Pair Corralation between ATyr Pharma and Antibe Therapeutics
If you would invest 22.00 in Antibe Therapeutics on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Antibe Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
ATyr Pharma vs. Antibe Therapeutics
Performance |
| Timeline |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Antibe Therapeutics |
ATyr Pharma and Antibe Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATyr Pharma and Antibe Therapeutics
The main advantage of trading using opposite ATyr Pharma and Antibe Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Antibe Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antibe Therapeutics will offset losses from the drop in Antibe Therapeutics' long position.| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
| Antibe Therapeutics vs. Brainsway | Antibe Therapeutics vs. Venus Concept | Antibe Therapeutics vs. Tactile Systems Technology | Antibe Therapeutics vs. Icecure Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |